X

Healio

Healio
Mirvetuximab Soravtansine Active in Previously Treated Ovarian Cancer

Mirvetuximab soravtansine induced confirmed objective response in about one-third of women with folate receptor alpha-high platinum-resistant ovarian cancer who previously received bevacizumab...

Healio
12/01/2021
Cytoreductive Surgery Before Chemotherapy Benefits Women With Recurrent Ovarian Cancer

Cytoreductive surgery before chemotherapy led to significant and clinically meaningful OS and PFS benefits for women with recurrent ovarian cancer, according to a phase 3 study. 

Healio
12/02/2021
FDA Approves Pafolacianine to Identify Ovarian Cancer Lesions During Surgery

Imaging drug pafolacianine, a targeted fluorescent imaging agent that that illuminates ovarian cancer intraoperatively, has been approved to help surgeons identify ovarian cancer lesions easier. 

Healio
11/30/2021
Stereotactic Ablative Radiotherapy Shows Long-Term Benefit in Operable Early NSCLC

Stereotactic ablative radiotherapy appeared as effective as surgery among patients with operable early-stage non-small cell lung cancer, according to new study results.

Healio
11/23/2021
Quizartinib Regimen Extends OS for Certain Patients With Acute Myeloid Leukemia

The addition of quizartinib to chemotherapy extended OS for certain adults with newly diagnosed acute myeloid leukemia, according to topline data released by the agent’s manufacturer.

Healio
11/22/2021
FDA Grants Fast Track Designation to Arfolitixorin for Metastatic Colorectal Cancer

The FDA granted fast track designation to arfolitixorin, a stabilized and biologically active pure form of folate, for treatment of patients with metastatic colorectal cancer. 

Healio
11/29/2021
FDA Grants RMAT Designation to CRISPR-Edited CAR-T for Advanced B-Cell Malignancies

The FDA granted regenerative medicine advanced therapy designation to CTX110, a CAR T-cell therapy in development for treatment of relapsed or refractory B-cell malignancies.

Healio
11/29/2021
Immunotherapy Combination Confers Durable Benefit in Advanced Renal Cell Carcinoma

First-line nivolumab plus ipilimumab conferred greater long-term clinical benefit than sunitinib for patients with advanced renal cell carcinoma, according to new study results. 

Healio
11/16/2021
Fasting-Mimicking Diet Safe, May Benefit Patients on Anticancer Therapy

A cyclic, 5-day fasting-mimicking diet appeared safe and showed potential to improve outcomes among patients on anticancer therapy for different tumor types, according to new study results. 

Healio
11/17/2021
FDA Approves Keytruda for Adjuvant Treatment of Renal Cell Carcinoma

The FDA expanded the approval of pembrolizumab to include adjuvant treatment of certain patients with renal cell carcinoma.

Healio
11/18/2021
Subscribe to Healio

source list reference

rgb(171, 222, 222)
#7d60d9
rgb(219, 18, 118)
#2694a4
#32a887
200, 66, 245
#85eb24
rgb(195, 2, 230)
rgb (247, 7, 79)
#352625
#4d4537
rgb(14, 133, 237)
rgb(252, 3, 223)
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
rgb(252, 186, 3)
#d2093c
#8e3f1c
rgb(242, 0, 137)
rgb (247, 7, 79)
#76b6c3
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
#bfcfc8
rgb (252, 186, 3)
#c61417
rgb(156, 242, 7)
rgb(91, 128, 189)
rgb(247, 139, 109)
#67e25b
#efef71
#03cffc
rgb(224, 4, 129)
#42fc9a
rgb(20, 13, 222)
rgb(84, 54, 94)
rgb(80, 147, 199)
rgb(117, 2, 247)
rgb(153, 146, 129)
#cc529a
#c59445
#c8cc0c
#bf6be3
rgb (245, 152, 2)
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
rgb(169, 196, 201)
#a153ac
rgb(5, 235, 235)
#e7f6e3
#6fc969
#9a8c2c
#a9c507
rgb(235, 190, 9)
#2b9ab3
#e61923
rgb(209, 227, 11)
#990677
#4a7bab
200, 66, 245
rgb (191, 171, 145)
#89f67c
#49a21d
rgb(126, 14, 237)
rbg(167, 124, 235)
rgb (132, 101, 173)
rgb((217, 11, 193)
#2c990a
rbg(16, 162, 230)
#d7da81
#f5ce42
rgb(217, 7, 192)
#575662
rgb (214, 104, 96)
rgb(224, 224, 4)
#a60538
rgb(2, 230, 230)
rgb(186, 130, 237)
rgb(235, 64, 52)
#49cde9
#c20fce
rgb(80,199,199)
#d95d39
#eb5834